Oruka Therapeutics to Present at Multiple November Investor Conferences

MENLO PARK, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced presentations at the following upcoming investor conferences: Stifel 2024 Healthcare ConferenceDate: Monday, November 18th, 2024Time: 2:25PM ET Jefferies London Healthcare ConferenceDate: Wednesday, November 20th, 2024Time: 2:00PM GMT A w ...